The compounds of the invention are inhibitors of alpha4 containing integrin-mediated binding to ligands such as VCAM-1 and MAdCAM.
US7166600B2
申请人:——
公开号:US7166600B2
公开(公告)日:2007-01-23
US7595399B2
申请人:——
公开号:US7595399B2
公开(公告)日:2009-09-29
Structure and Biocatalytic Scope of Coclaurine
<i>N</i>
‐Methyltransferase
作者:Matthew R. Bennett、Mark L. Thompson、Sarah A. Shepherd、Mark S. Dunstan、Abigail J. Herbert、Duncan R. M. Smith、Victoria A. Cronin、Binuraj R. K. Menon、Colin Levy、Jason Micklefield
DOI:10.1002/anie.201805060
日期:2018.8.13
plant secondary metabolites, which have been exploited to develop analgesics, antibiotics, antitumor agents, and other therapeutic agents. Biosynthesis of BIAs proceeds via a common pathway from tyrosine to (S)‐reticulene at which point the pathway diverges. Coclaurine N‐methyltransferase (CNMT) is a key enzyme in the pathway to (S)‐reticulene, installing the N‐methyl substituent that is essential for